The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910415 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Annagrazia Adornetto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. Hauptthemen laut MEDLINE: Amitriptyline, Autophagy, Cell Proliferation, Neuroblastoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amitriptyline is a tricyclic antidepressant commonly used for depressive disorders and is prescribed off-label for several neurological conditions like neuropathic pain, migraines and anxiety. Besides their action on the reuptake of monoaminergic neurotransmitters, tricyclic antidepressants interact with several additional targets that may contribute to either therapeutic or adverse effects. Here, we investigated the effects of amitriptyline on proliferation and autophagy (i.e., an evolutionarily conserved catabolic pathway responsible for the degradation and recycling of cytoplasmic material) in human SH-SY5Y neuroblastoma cell cultures. The dose and time-dependent upregulation of the autophagy marker LC3II and the autophagy receptor p62, with the accumulation of LAMP1 positive compartments, were observed in SH-SY5Y cells exposed to the amitriptyline. These effects were accompanied by reduced cell viability and decreased clonogenic capacity, without a significant induction of apoptosis. Decrease viability and clonogenic activity were still observed in autophagy deficient Atg5−/− MEF and following pre-treatment of SH-SY5Y culture with the autophagy inhibitor chloroquine, suggesting that they were independent from autophagy modulation. Our findings demonstrate that amitriptyline acts on pathways crucial for cell and tissue homeostasis (i.e., autophagy and proliferation) and pose the basis for further studies on the potential therapeutic application of amitriptyline, as well as the consequences of its use for long-term treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
- School of Hospital Pharmacy, Department of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
ORCID-Profile: Annagrazia Adornetto, Andrea Satriano, Ester Licastro, Maria Tiziana Corasaniti, Giacinto Bagetta, Rossella Russo
Zitieren
APA
Adornetto, A., Laganà, M. L., Satriano, A., Licastro, E., Corasaniti, M. T., Bagetta, G., & Russo, R. (2024). The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910415
Vancouver
Adornetto A, Laganà ML, Satriano A, Licastro E, Corasaniti MT, Bagetta G, et al. The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910415
BibTeX
@article{Adornetto2024,
author = {Adornetto, Annagrazia and Laganà, Maria Luisa and Satriano, Andrea and Licastro, Ester and Corasaniti, Maria Tiziana and Bagetta, Giacinto and Russo, Rossella},
title = {The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910415}
}
EUVIMED